Daniel Westaby
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 6
- Prostate Cancer Diagnosis and Treatment 1
-
- Cancer, Lipids, and Metabolism 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- Johann S. de Bono (7 shared papers)Adam Sharp (6 shared papers)Juan M. Jiménez‐Vacas (2 shared papers)Maria D. Fenor de la Maza (6 shared papers)Alec Paschalis (1 shared paper)Jon Welti (1 shared paper)Steven P. Balk (1 shared paper)Andreas Varkaris (1 shared paper)
- Journals
- The Annual Review of Pharmacology and Toxicology (1 paper)BMC Pregnancy and Childbirth (1 paper)Laboratory Investigation (1 paper)American Society of Clinical Oncology Educational Book (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesChile
In The Last Decade
Daniel Westaby
8 papers receiving 148 citations
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 76
- Cancer Research 28
- Oncology 21
- Molecular Biology 54
- Genetics 13
Countries citing papers authored by Daniel Westaby
This map shows the geographic impact of Daniel Westaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Westaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Westaby more than expected).
Fields of papers citing papers by Daniel Westaby
This network shows the impact of papers produced by Daniel Westaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Westaby. The network helps show where Daniel Westaby may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Westaby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 81 | |
| 2 | 2021 | 31 | |
| 3 | 2021 | 15 | |
| 4 | 2012 | 9 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 4 | |
| 7 | 2023 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 0 |
About Daniel Westaby
Daniel Westaby is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 149 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Ubiquitin and proteasome pathways (1 paper) and Radiation Effects in Electronics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (76 citations), Cancer Research (28 citations), Oncology (21 citations), Molecular Biology (54 citations) and Genetics (13 citations). Daniel Westaby has collaborated with scholars based in United Kingdom, United States and Chile. Frequent co-authors include Johann S. de Bono, Adam Sharp, Juan M. Jiménez‐Vacas, Maria D. Fenor de la Maza, Alec Paschalis, Jon Welti, Steven P. Balk, Andreas Varkaris, Paul V. Viscuse and Olívia Wu. Their work appears in journals such as The Annual Review of Pharmacology and Toxicology, BMC Pregnancy and Childbirth, Laboratory Investigation, American Society of Clinical Oncology Educational Book and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.